Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| IQV - IQVIA | 3.45% | Reduce −0.2% | 3,207,582 | $181.14 | $581M | −6,000 | −$116M |
| TMO - Thermo Fisher Scientific | 3.38% | Reduce −9.7% | 1,122,059 | $507.19 | $569M | −120,400 | −$106M |
| Change Healthcare | 2.95% | New | 18,076,272 | $27.49 | $497M | +18,076,272 | +$497M |
| ARMK - Aramark | 2.95% | Reduce −0.5% | 15,921,642 | $31.20 | $497M | −86,375 | +$6M |
| BSX - Boston Scientific | 2.80% | Reduce −19.2% | 12,151,257 | $38.73 | $471M | −2,896,000 | −$90M |
| TRU - Transunion | 2.80% | Add +6.0% | 7,907,895 | $59.49 | $470M | +444,899 | −$127M |
| CLVT - Clarivate | 2.26% | Add +65.1% | 40,546,300 | $9.39 | $381M | +15,988,500 | +$40M |
| ELV - Elevance Health | 2.16% | Reduce −3.0% | 801,400 | $454.24 | $364M | −25,082 | −$35M |
| 2.02% | New | 7,755,000 | $43.84 | $340M | +7,755,000 | +$340M | |
| MSFT - Microsoft | 1.99% | Add +13.1% | 1,439,178 | $232.90 | $335M | +166,300 | +$8M |
| CNC - Centene Del | 1.97% | Reduce −2.1% | 4,252,141 | $77.81 | $331M | −89,053 | −$36M |
| GOOG - Alphabet · CL C | 1.93% | Add +2250.7% | 3,371,140 | $96.15 | $324M | +3,227,733 | +$10M |
| AZNN — | 1.82% | Add +20.6% | 5,584,962 | $54.84 | $306M | +955,000 | +$377K |
| EFX - Equifax | 1.82% | Add +10.4% | 1,785,097 | $171.43 | $306M | +167,740 | +$10M |
| HWM - Howmet Aerospace | 1.81% | Reduce −28.9% | 9,842,353 | $30.93 | $304M | −3,995,000 | −$131M |
| MA - Mastercard · CL A | 1.81% | Reduce −7.2% | 1,068,371 | $284.34 | $304M | −82,900 | −$59M |
| CRM - Salesforce | 1.76% | Add +17.2% | 2,060,938 | $143.84 | $296M | +302,000 | +$6M |
| YMM - Full Truck Alliance | 1.76% | Add +13.8% | 45,164,743 | $6.55 | $296M | +5,489,000 | −$64M |
| BHVN - Biohaven | 1.75% | New | 1,947,820 | $151.17 | $294M | +1,947,820 | +$294M |
| WAB - Wabtec | 1.69% | Reduce −12.2% | 3,502,930 | $81.35 | $285M | −487,003 | −$43M |
| V - VISA · CL A | 1.60% | Add +3.4% | 1,512,210 | $177.65 | $269M | +49,400 | −$19M |
| SHW - Sherwin Williams | 1.56% | Add +20.4% | 1,279,492 | $204.75 | $262M | +216,900 | +$24M |
| BX - Blackstone | 1.55% | Add +10.4% | 3,114,951 | $83.70 | $261M | +293,500 | +$3M |
| DT - Dynatrace | 1.49% | Reduce −8.2% | 7,202,000 | $34.81 | $251M | −645,000 | −$59M |
| META - Meta Platforms · CL A | 1.46% | Add +1.5% | 1,807,040 | $135.68 | $245M | +26,000 | −$42M |
| NYT - New York Times · CL A | 1.34% | Add +13.8% | 7,828,073 | $28.75 | $225M | +947,269 | +$33M |
| SPGI - S&P Global | 1.30% | Add +118.1% | 717,500 | $305.35 | $219M | +388,500 | +$108M |
| AON - AON PLC · CL A | 1.29% | Reduce −12.9% | 808,486 | $267.87 | $217M | −120,000 | −$34M |
| CSGP - Costar Group | 1.23% | Reduce −40.4% | 2,960,185 | $69.65 | $206M | −2,003,000 | −$94M |
| ADBE - Adobe Systems | 1.14% | Reduce −2.3% | 694,772 | $275.20 | $191M | −16,000 | −$69M |
| NOW - Servicenow | 1.11% | Add +0.7% | 493,550 | $377.61 | $186M | +3,400 | −$47M |
| BEKE - KE | 1.04% | Hold | 9,958,500 | $17.52 | $174M | — | — |
| BEAM - Beam Therapeutics | 1.03% | Add +4.6% | 3,631,271 | $47.64 | $173M | +159,000 | +$39M |
| EXEL - Exelixis | 1.00% | Add +4.9% | 10,675,844 | $15.68 | $167M | +501,571 | −$44M |
| XYZ - Block · CL A | 0.84% | Reduce −9.0% | 2,584,000 | $54.99 | $142M | −255,000 | −$32M |
| HUM - Humana | 0.72% | New | 251,200 | $485.19 | $122M | +251,200 | +$122M |
| CVS - Cvs Health | 0.71% | Add +0.8% | 1,256,259 | $95.37 | $120M | +10,000 | +$4M |
| UTHR - United Therapeutics | 0.68% | Add +40.0% | 549,673 | $209.38 | $115M | +156,977 | +$23M |
| Horizon Therapeutics Pub L | 0.65% | Add +62.9% | 1,780,223 | $61.89 | $110M | +687,063 | +$110M |
| ABBV - Abbvie | 0.58% | Add +43.4% | 725,112 | $134.21 | $97M | +219,597 | +$20M |
| ALNY - Alnylam Pharmaceuticals | 0.51% | Reduce −45.6% | 428,456 | $200.16 | $86M | −359,454 | −$29M |
| INSP - Inspire Med Sys | 0.51% | Add +16.7% | 481,996 | $177.37 | $85M | +68,996 | +$10M |
| Sarepta Therapeutics | 0.50% | Reduce −36.3% | 754,950 | $110.54 | $83M | −430,101 | −$5M |
| BIIB - Biogen | 0.48% | Add +9.7% | 305,499 | $267.00 | $82M | +27,000 | +$25M |
| Masimo | 0.48% | Add +195.9% | 577,000 | $141.16 | $81M | +382,000 | +$56M |
| ENTA - Enanta Pharmaceuticals | 0.48% | Hold | 1,550,000 | $51.87 | $80M | — | — |
| PCG - Pg And E | 0.47% | Hold | 6,305,142 | $12.50 | $79M | — | — |
| CYTK - Cytokinetics | 0.47% | Reduce −27.8% | 1,621,038 | $48.45 | $79M | −624,000 | −$10M |
| AVTR - Avantor | 0.43% | Reduce −30.3% | 3,679,464 | $19.60 | $72M | −1,600,000 | −$92M |
| JAZZ - Jazz Pharmaceuticals | 0.43% | Reduce −41.6% | 537,500 | $133.29 | $72M | −382,600 | −$72M |
| Nielsen | 0.41% | New | 2,470,976 | $27.72 | $68M | +2,470,976 | +$68M |
| Lufax · CL A | 0.31% | Reduce −13.5% | 20,536,399 | $2.54 | $52M | −3,204,000 | −$90M |
| BRKR - Bruker | 0.30% | Reduce −32.9% | 943,800 | $53.06 | $50M | −463,000 | −$38M |
| RVMD - Revolution Medicines | 0.29% | Reduce −23.1% | 2,500,000 | $19.72 | $49M | −750,000 | −$14M |
| Laboratory Amer | 0.26% | Reduce −58.5% | 215,314 | $204.81 | $44M | −303,400 | −$77M |
| AGIO - Agios Pharmaceuticals | 0.25% | Add +12.3% | 1,496,829 | $28.28 | $42M | +163,817 | +$13M |
| Chemocentryx | 0.25% | New | 800,000 | $51.66 | $41M | +800,000 | +$41M |
| Imago Biosciences | 0.22% | Hold | 2,471,313 | $15.05 | $37M | — | — |
| BABA - Alibaba Group | 0.22% | New | 464,000 | $79.99 | $37M | +464,000 | +$37M |
| Catalent | 0.20% | Add +11.0% | 465,755 | $72.36 | $34M | +46,000 | −$11M |
| APLSUSD - Apellis Pharmaceuticals | 0.19% | New | 478,000 | $68.30 | $33M | +478,000 | +$33M |
| Ironsource · CL A | 0.19% | New | 9,130,000 | $3.44 | $31M | +9,130,000 | +$31M |
| PTGX - Protagonist Therapeutics | 0.18% | Reduce −1.3% | 3,651,887 | $8.43 | $31M | −48,721 | +$2M |
| Holding | 0.18% | New | 450,000 | $68.10 | $31M | +450,000 | +$31M |
| Marblegate Acquisition · CL A | 0.18% | Hold | 2,970,000 | $9.96 | $30M | — | — |
| Holding · CL A | 0.16% | Hold | 2,809,000 | $9.78 | $27M | — | — |
| Broadmark Rlty Cap | 0.15% | Hold | 4,850,000 | $5.11 | $25M | — | — |
| Holding · CL A | 0.15% | Hold | 2,500,000 | $9.81 | $25M | — | — |
| Metals Acquisition · CL A | 0.15% | Hold | 2,489,700 | $9.81 | $24M | — | — |
| Berenson Acquisition I · CL A | 0.14% | Hold | 2,475,000 | $9.84 | $24M | — | — |
| Iveric Bio | 0.14% | New | 1,317,000 | $17.94 | $24M | +1,317,000 | +$24M |
| Cara Therapeutics | 0.14% | Hold | 2,500,000 | $9.36 | $23M | — | — |
| Swiftmerge Acquisition · CLASS A | 0.12% | Hold | 1,980,000 | $9.93 | $20M | — | — |
| Revolution Healthcar Aq · CLASS A | 0.12% | Hold | 2,000,000 | $9.83 | $20M | — | — |
| Holding · CLASS A | 0.11% | Hold | 1,900,000 | $9.82 | $19M | — | — |
| Karuna Therapeutics | 0.11% | Reduce −20.0% | 80,000 | $224.92 | $18M | −20,000 | +$5M |
| Amyris | 0.11% | Reduce −71.1% | 6,126,642 | $2.92 | $18M | −15,083,240 | −$21M |
| Holding · CLASS A | 0.10% | Hold | 1,732,500 | $9.97 | $17M | — | — |
| Holding · CL A | 0.10% | Hold | 1,750,000 | $9.84 | $17M | — | — |
| Sdcl Edge Acquisition · CL A | 0.10% | Hold | 1,732,500 | $9.89 | $17M | — | — |
| Vector Acquisition Ii · CL A | 0.10% | Hold | 1,700,000 | $9.92 | $17M | — | — |
| Shelter Acquisition I · CLASS A | 0.10% | Hold | 1,650,000 | $9.91 | $16M | — | — |
| Savara | 0.09% | Add +3.5% | 9,908,086 | $1.55 | $15M | +330,813 | +$801K |
| Big Sky Growth Partners · CLASS A | 0.09% | Hold | 1,550,000 | $9.78 | $15M | — | — |
| KKR - Kkr Acquisition I · CLASS A | 0.09% | Hold | 1,500,000 | $9.84 | $15M | — | — |
| Holding · CL A | 0.09% | Hold | 1,500,000 | $9.81 | $15M | — | — |
| Ares Acquisition · CL A | 0.08% | Hold | 1,425,000 | $9.93 | $14M | — | — |
| Humanco Acquisition · CL A | 0.08% | Hold | 1,407,749 | $9.96 | $14M | — | — |
| Disruptive Acquisition · CLASS A | 0.08% | Hold | 1,400,000 | $9.94 | $14M | — | — |
| Holding · CLASS A | 0.08% | Hold | 1,360,040 | $9.84 | $13M | — | — |
| Generation Bio | 0.08% | Reduce −13.7% | 2,500,000 | $5.31 | $13M | −397,300 | −$6M |
| Holding · CL A | 0.08% | New | 486,902 | $26.75 | $13M | +486,902 | +$13M |
| Holding · CL A | 0.07% | Hold | 1,250,000 | $9.83 | $12M | — | — |
| Agile Growth · CLASS A | 0.07% | Hold | 1,200,000 | $9.93 | $12M | — | — |
| Holding · CL A | 0.07% | Hold | 1,208,326 | $9.85 | $12M | — | — |
| Tcv Acquisition · CL A | 0.07% | Hold | 1,211,459 | $9.82 | $12M | — | — |
| Nightdragon Acquisition · CLASS A | 0.07% | Hold | 1,200,000 | $9.82 | $12M | — | — |
| Gores Vii · CL A | 0.07% | Hold | 1,150,162 | $9.86 | $11M | — | — |
| Tiga Acquisition · CL A | 0.07% | Hold | 1,080,000 | $10.38 | $11M | — | — |
| Holding · CL A | 0.07% | Hold | 1,120,102 | $9.92 | $11M | — | — |
| Tpg Pace Beneficial Ii | 0.06% | Hold | 1,116,833 | $9.78 | $11M | — | — |
| GPOR - Gulfport Energy | 0.06% | Reduce −22.6% | 116,408 | $88.29 | $10M | −33,918 | −$2M |
| Concord Acquisition · CL A | 0.06% | Hold | 1,005,100 | $10.05 | $10M | — | — |
| NTRA - Natera | 0.06% | Reduce −1.1% | 227,953 | $43.82 | $10M | −2,599 | +$2M |
| Holding · CLASS A | 0.06% | Hold | 1,000,000 | $9.91 | $10M | — | — |
| Churchill Capital Vii · CL A | 0.06% | Hold | 1,000,000 | $9.83 | $10M | — | — |
| Forum Merger Iv · CLASS A | 0.06% | Hold | 1,000,000 | $9.82 | $10M | — | — |
| Churchill Capital Vi · CL A | 0.06% | Hold | 997,767 | $9.83 | $10M | — | — |
| Legend Biotech | 0.06% | New | 237,714 | $40.80 | $10M | +237,714 | +$10M |
| Screaming Eagle Acquisitn · CLASS A | 0.06% | Hold | 1,000,000 | $9.68 | $10M | — | — |
| CRBU - Caribou Biosciences | 0.06% | Reduce −59.3% | 896,369 | $10.55 | $9M | −1,307,526 | −$3M |
| Holding · CL A | 0.05% | Hold | 900,000 | $10.06 | $9M | — | — |
| Atento S A | 0.05% | Hold | 2,230,357 | $4.04 | $9M | — | — |
| Interprivate Ii Acquisition · CL A | 0.05% | Hold | 882,647 | $9.84 | $9M | — | — |
| Rxr Acquisition · CLASS A | 0.05% | Hold | 854,961 | $9.84 | $8M | — | — |
| Holding · CLASS A | 0.05% | Hold | 843,046 | $9.82 | $8M | — | — |
| Holding · CLASS A | 0.05% | Hold | 835,638 | $9.89 | $8M | — | — |
| Holding | 0.05% | Hold | 848,184 | $9.69 | $8M | — | — |
| Holding · CL A | 0.05% | Hold | 800,000 | $9.94 | $8M | — | — |
| Arya Sciences Acqu Iv · CL A | 0.05% | Hold | 800,000 | $9.92 | $8M | — | — |
| Levere · CLASS A | 0.05% | Hold | 800,000 | $9.90 | $8M | — | — |
| Landcadia Iv · CLASS A | 0.05% | Hold | 802,028 | $9.83 | $8M | — | — |
| Holding · CL A | 0.05% | Hold | 775,200 | $9.97 | $8M | — | — |
| Holding · CLASS A | 0.04% | Hold | 750,000 | $10.00 | $8M | — | — |
| Pathfinder Acquisition · CL A | 0.04% | Hold | 750,000 | $9.94 | $7M | — | — |
| Holding · CL A | 0.04% | Hold | 750,000 | $9.92 | $7M | — | — |
| Holding · CL A | 0.04% | Hold | 750,000 | $9.87 | $7M | — | — |
| Social Leverage Acquisn · CL A | 0.04% | Hold | 750,000 | $9.83 | $7M | — | — |
| Research Alliance Ii · CL A | 0.04% | Hold | 750,000 | $9.82 | $7M | — | — |
| Panacea Acquisition Ii · CL A | 0.04% | Hold | 750,000 | $9.80 | $7M | — | — |
| Holding · CLASS A | 0.04% | Hold | 745,000 | $9.85 | $7M | — | — |
| Holding · CL A | 0.04% | Hold | 700,000 | $9.91 | $7M | — | — |
| Khosla Ventures Acquisition · CL A | 0.04% | Hold | 700,000 | $9.80 | $7M | — | — |
| Corsair Partnering · CL A | 0.04% | Hold | 700,000 | $9.79 | $7M | — | — |
| Gores Viii · CL A | 0.04% | Hold | 692,810 | $9.87 | $7M | — | — |
| NUVB - Nuvation Bio · CL A | 0.04% | Hold | 2,900,000 | $2.24 | $6M | — | — |
| Rocket Internet Grwt Oprt · CL A | 0.04% | Hold | 647,945 | $9.91 | $6M | — | — |
| Rcf Acquisition · CL A | 0.04% | Hold | 600,000 | $10.09 | $6M | — | — |
| Holding · CLASS A | 0.04% | Hold | 600,000 | $9.85 | $6M | — | — |
| Finserv Acquisition Ii · CL A | 0.04% | Hold | 600,000 | $9.84 | $6M | — | — |
| SLAM · CL A | 0.03% | Hold | 570,396 | $9.91 | $6M | — | — |
| Blue Whale Acquisition · CLASS A | 0.03% | Hold | 575,000 | $9.70 | $6M | — | — |
| Tio Tech A · CLASS A | 0.03% | Hold | 502,001 | $9.89 | $5M | — | — |
| Ftac Hera Acquisition · CLASS A | 0.03% | Hold | 500,000 | $9.93 | $5M | — | — |
| G Squared Ascend I · CL A | 0.03% | Hold | 500,000 | $9.93 | $5M | — | — |
| Holding · CL A | 0.03% | Hold | 500,000 | $9.92 | $5M | — | — |
| Gores Ix · CLASS A | 0.03% | Hold | 500,000 | $9.68 | $5M | — | — |
| Ready Capital | 0.03% | Hold | 472,537 | $10.14 | $5M | — | — |
| Holding · CL A | 0.03% | Hold | 484,709 | $9.79 | $5M | — | — |
| VNET - VNET Group | 0.03% | New | 825,000 | $5.50 | $5M | +825,000 | +$5M |
| Scion Tech Growth Ii · CL A | 0.03% | Hold | 450,000 | $9.94 | $4M | — | — |
| Holding · CLASS A | 0.03% | Hold | 452,519 | $9.83 | $4M | — | — |
| Ldh Growth I · CLASS A | 0.03% | Hold | 436,702 | $9.91 | $4M | — | — |
| Svf Investment · CL A | 0.03% | Hold | 425,000 | $9.96 | $4M | — | — |
| Vpc Impact Acquisition · CLASS A | 0.03% | Hold | 425,000 | $9.93 | $4M | — | — |
| Lamf Global Ventures I · CLASS A | 0.02% | Hold | 400,000 | $10.09 | $4M | — | — |
| Holding · CL A | 0.02% | Hold | 400,000 | $9.84 | $4M | — | — |
| Holding · CLASS A | 0.02% | Hold | 400,000 | $9.82 | $4M | — | — |
| COGT - Cogent Biosciences | 0.02% | Reduce −75.5% | 245,139 | $14.92 | $4M | −754,861 | −$5M |
| Cartica Acquisition · CLASS A | 0.02% | Hold | 350,000 | $10.11 | $4M | — | — |
| Holding · CLASS A | 0.02% | Hold | 350,000 | $10.03 | $4M | — | — |
| Uta Acquisition · CLASS A | 0.02% | Hold | 344,100 | $10.02 | $3M | — | — |
| ALVO - Alvotech | 0.02% | Hold | 500,000 | $6.76 | $3M | — | — |
| Exscientia | 0.02% | New | 400,000 | $8.21 | $3M | +400,000 | +$3M |
| Sound Point Acquisition · CLASS A | 0.02% | Hold | 300,000 | $10.19 | $3M | — | — |
| Holding · CLASS A | 0.02% | Hold | 300,000 | $10.09 | $3M | — | — |
| Holding | 0.02% | Hold | 810,500 | $3.72 | $3M | — | — |
| Holding · CL A | 0.02% | Hold | 304,698 | $9.82 | $3M | — | — |
| Lazard Growth Acquisition · CL A | 0.02% | Hold | 300,000 | $9.92 | $3M | — | — |
| Broadscale Acquisition · CL A | 0.01% | Hold | 250,000 | $9.85 | $2M | — | — |
| Hudson Executive Inves Iii · CL A | 0.01% | Hold | 250,000 | $9.84 | $2M | — | — |
| Live Oak Mobility Acquisi · CL A | 0.01% | Hold | 250,000 | $9.83 | $2M | — | — |
| Ventyx Biosciences | 0.01% | Reduce −92.5% | 70,000 | $34.91 | $2M | −860,648 | −$9M |
| Liberty Media Acquisition | 0.01% | Hold | 210,000 | $9.94 | $2M | — | — |
| Arctos Northstar Acquis · CL A | 0.01% | Hold | 200,000 | $9.91 | $2M | — | — |
| Better Therapeutics | 0.01% | Hold | 1,000,000 | $1.76 | $2M | — | — |
| Clever Leaves | 0.01% | Hold | 2,466,892 | $0.6020 | $1M | — | — |
| BHVN - Biohaven | 0.01% | New | 235,000 | $6.30 | $1M | +235,000 | +$1M |
| Priveterra Acquisition · CL A | 0.01% | Hold | 150,000 | $9.85 | $1M | — | — |
| Theseus Pharmaceuticals | 0.01% | Reduce −45.5% | 223,149 | $5.80 | $1M | −186,568 | −$972K |
| The Music Acquisition · CLASS A | 0.01% | Hold | 125,000 | $9.86 | $1M | — | — |
| TNGX - Tango Therapeutics | 0.01% | Hold | 300,000 | $3.62 | $1M | — | — |
| Crypto 1 Acquisition · CLASS A | 0.01% | Hold | 100,000 | $10.04 | $1M | — | — |
| NTRS - Northern Trust · CL A | 0.01% | Hold | 100,000 | $9.85 | $985K | — | — |
| NTRS - Northern Trust · CL A | 0.01% | Hold | 100,000 | $9.83 | $983K | — | — |
| OKLO - Altc Acquisition · CL A | 0.01% | Hold | 98,300 | $9.76 | $959K | — | — |
| Summit Midstream Partners | 0.00% | Hold | 43,055 | $15.03 | $647K | — | — |
| Ion Acquisition 3 · CL A | 0.00% | Hold | 56,151 | $9.87 | $554K | — | — |
| Avrobio | 0.00% | Hold | 740,000 | $0.6419 | $475K | — | — |
| EDU — | 0.00% | Hold | 13,000 | $24.00 | $312K | — | — |
| Holding | 0.00% | Hold | 85,838 | $3.29 | $282K | — | — |
Showing top 50 of 191 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2022 Q2
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| COHR - Coherent | 0.95% | Exit | 0 | $266.22 | $154M | −577,982 | −$154M |
| TSM - Taiwan Semiconductor Mfg | 0.57% | Exit | 0 | $81.75 | $92M | −1,126,125 | −$92M |
| Blueprint Medicines | 0.38% | Exit | 0 | $50.51 | $61M | −1,211,987 | −$61M |
| IOVA - Iovance Biotherapeutics | 0.22% | Exit | 0 | $11.04 | $35M | −3,176,773 | −$35M |
| Vonage | 0.20% | Exit | 0 | $18.84 | $33M | −1,727,000 | −$33M |
| Holding · CL A | 0.17% | Exit | 0 | $19.97 | $27M | −1,350,500 | −$27M |
| NVAX - Novavax | 0.16% | Exit | 0 | $51.43 | $26M | −498,000 | −$26M |
| Radius Health | 0.13% | Exit | 0 | $10.37 | $22M | −2,107,400 | −$22M |
| Sanderson Farms | 0.11% | Exit | 0 | $215.52 | $17M | −80,000 | −$17M |
| Healthcare Tr Amer · CL A | 0.09% | Exit | 0 | $27.91 | $14M | −500,000 | −$14M |
| Holding · CLASS A | 0.06% | Exit | 0 | $9.95 | $10M | −985,300 | −$10M |
| Cdk Global | 0.04% | Exit | 0 | $54.77 | $6M | −106,514 | −$6M |
| QTRX - Quanterix | 0.03% | Exit | 0 | $16.19 | $4M | −260,000 | −$4M |
| RCEL - Avita Medical | 0.02% | Exit | 0 | $4.75 | $3M | −580,000 | −$3M |
| Ikena Oncology | 0.01% | Exit | 0 | $4.43 | $1M | −290,000 | −$1M |
| Lianbio | 0.01% | Exit | 0 | $2.16 | $1M | −500,000 | −$1M |
| ANNX - Annexon | — | Exit | 0 | $3.77 | $490K | −130,000 | −$490K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2